The company pulled Harmony from the market about a year ago following six reports of the capsule at the end of its delivery catheter breaking.
Medtronic is bringing its Harmony transcatheter pulmonary valve (TPV) back to the US market nearly a year after recalling it.
The company pulled Harmony from the market in March 2022, about a year after the US Food and Drug Administration approved it as a treatment for severe pulmonary valve regurgitation in patients with a congenital malformation of the right ventricular outflow tract
Haemonetics will acquire Quebec-based OpSens for CAD $2.90 per share, or about US $253m at current exchange rates. Haemonetics expects OpSens' fiber-optic technology to complement its interventional cardiology portfolio.
The retail giant will sell the Dexcom G7 continuous glucose monitoring system to eligible customers through a new online platform.
Stimdia is trying to restore respiratory function in ICU patients with phrenic nerve stimulation.
Reuters reported that global private equity firm Carlyle Group has offered to pay at least $7bn for Medtronic’s patient monitoring and respiratory interventions businesses. Medtronic announced its plan to get out of those businesses about one year ago.
